Skip to content

Company

Rocket Pharmaceuticals

RCKT · United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Rocket Pharmaceuticals?

Held by 43 covered funds. Sorted by Rocket Pharmaceuticals’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
BBCVirtus LifeSci Biotech Clinical Trials0.8%
GNOMGlobal X Genomics & Biotechnology0.3%
WDNAWisdomTree BioRevolution Fund0.3%
FSCCFederated Hermes MDT Small Cap Core0.1%
RFLRInnovator U.S. Small Cap Managed Floor0.1%
IWCiShares Micro-Cap0.1%
FSEVFidelity Enhanced Small Cap Value0.1%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
IBBiShares Biotechnology0.0%
FESMFidelity Enhanced Small Cap Core0.0%
IBBQInvesco Nasdaq Biotechnology0.0%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.0%
IWNiShares Russell 2000 Value0.0%
VTWVVanguard Russell 2000 Value Index Fund0.0%
RESMColumbia Research Enhanced Small Cap0.0%
AVSCAvantis U.S. Small Cap Equity0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
IWMiShares Russell 20000.0%
NSIDXSmall Cap Index Fund0.0%
RSSLGlobal X Russell 20000.0%
VTWOVanguard Russell 2000 Index Fund0.0%
SCHASchwab U.S. Small-Cap0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
ITWOProShares Russell 2000 High Income0.0%
DFASDimensional U.S. Small Cap0.0%
VHTVanguard Health Care Index Fund0.0%
DXUVDimensional US Vector Equity0.0%
VXFVanguard Extended Market Index Fund0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
VTWGVanguard Russell 2000 Growth Index Fund0.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
DCORDimensional US Core Equity 10.0%
DFACDimensional U.S. Core Equity 20.0%
DFAUDimensional US Core Equity Market0.0%
DFUSDimensional U.S. Equity Market0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
SCHBSchwab U.S. Broad Market0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTIVanguard Total Stock Market Index Fund0.0%
IWViShares Russell 30000.0%
VTHRVanguard Russell 3000 Index Fund0.0%
SSBIXState Street Balanced Index Fund0.0%
AVSUAvantis Responsible U.S. Equity0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Rocket Pharmaceuticals news

No recent stories about Rocket Pharmaceuticals.